Search

everythinglearnresearchcommunity

for

Search:↓

Eclipta prostrata has many medicinal benefits, but more research is needed to understand how it works.

Immune cells are essential for early hair and skin development and healing.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Probiotics show promise for health benefits but need more research to understand how they work.

Skin cancer often starts from Lgr5+ progenitor cells.

Wounded skin cells can revert to stem cells and help heal.

Hand and forearm transplants can be successful long-term, but they come with challenges like rejection and side effects from immunosuppression.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

No single treatment is clearly effective for central serous chorioretinopathy.

HAPLN1 can promote hair growth and may help treat hair loss.

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

Some cats with sudden hair loss and tiredness might have cancer-related alopecia.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.